The investment in Biopreparat reflected a Soviet calculus that biological agents could provide asymmetrical leverage against the West.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results